Your browser doesn't support javascript.
loading
Blockade of only TGF-ß 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapy.
Terabe, Masaki; Robertson, Faith C; Clark, Katharine; De Ravin, Emma; Bloom, Anja; Venzon, David J; Kato, Shingo; Mirza, Amer; Berzofsky, Jay A.
Afiliação
  • Terabe M; Vaccine Branch and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Robertson FC; Vaccine Branch and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Clark K; Vaccine Branch and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • De Ravin E; Vaccine Branch and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Bloom A; Vaccine Branch and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Venzon DJ; Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Kato S; Vaccine Branch and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Mirza A; XOMA Corporation, Barkeley, CA, USA.
  • Berzofsky JA; Vaccine Branch and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Oncoimmunology ; 6(5): e1308616, 2017.
Article em En | MEDLINE | ID: mdl-28638730
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Qualitative_research Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Qualitative_research Idioma: En Ano de publicação: 2017 Tipo de documento: Article